Pharmaceutical Industry Related Content
The UK’s doomed Medical Cannabis (Access) Bill
Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP, explore the UK’s doomed Medical Cannabis (Access) Bill
Antimicrobial resistance now kills more people than HIV or malaria
According to a new study in The Lancet, antimicrobial resistance is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.
New Pfizer Covid-19 pill seeking emergency use authorization from FDA
Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™
How to compete with COVID-19 with a computer?
Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.
Pfizer COVID-19 pill 89% effective against death
Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.
TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?
BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).
The risks of anabolic steroids
Dr Deborah Lee, Dr Fox Online Pharmacy, explores the risks associated with anabolic steroids and how to get help if you have an addiction.
Are you eligible for the COVID-19 booster jab?
Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.
New EU rules on veterinary medicines to support responsible use of antibiotics
Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.
Mirtazapine not effective in treating dementia patients
Mirtazapine, an antidepressant drug given to dementia patients, has been found to be no more effective than a placebo and increases mortality.
Risk of pregnancy loss not associated with COVID-19 vaccines
According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.
FDA approves Pfizer booster vaccine for over 65s
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
Changing the treatment paradigm in Inflammatory Bowel Diseases
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.
The impact and importance of psychedelic medicine
Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.
COVID-19 vaccines: Risks versus benefits
Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.
Glycoscience offers opportunities galore in healthcare
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.
Malaria deaths reduced by 70% with vaccine and drug combination
A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.
Five new research projects will examine COVID-19 vaccine responses
Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.
UK orders 35 million more Pfizer/BioNTech vaccine doses
The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..
Benchmarking Regulatory systems governing veterinary medicines – part 3
Rick Clayton, Technical Director, AnimalhealthEurope, in the final chapter of this three-part series, examines the benefits of benchmarking regulatory systems and promoting Good Regulatory Practice.